Report Detail

Request for Sample of this report

Pharma & Healthcare Global Influenza Drugs Market Research Report 2019 by Manufacturers, Regions, Types and Applications

  • RnM3513637
    • |
  • 03 August, 2020
    • |
  • Global
    • |
  • 119 Pages
    • |
  • XYZResearch
    • |
  • Pharma & Healthcare

According to XYZResearch study, over the next five years the Influenza Drugsmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Drugsbusiness.
Influenza Drugs market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Influenza Drugs for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

Global Influenza Drugs market competition by top manufacturers/players, with Influenza Drugs sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Influenza Drugs for each application, including
Adults
Chidren

Feel free to let me know if you have any special requirements.


Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Influenza Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Zanamivir
      • 2.1.2 Oseltamivir Phosphate
      • 2.1.3 Peramivir
      • 2.1.4 Other Influenza Drugs
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Zanamivir
      • 2.2.2 Oseltamivir Phosphate
      • 2.2.3 Peramivir
      • 2.2.4 Other Influenza Drugs

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Adults
      • 3.1.2 Chidren

    4 Manufacturers Profiles/Analysis

    • 4.1 Bristol-Myers Squibb]
      • 4.1.1 Bristol-Myers Squibb] Profiles
      • 4.1.2 Bristol-Myers Squibb] Product Information
      • 4.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Bristol-Myers Squibb] SWOT Analysis
    • 4.2 AstraZeneca
      • 4.2.1 AstraZeneca Profiles
      • 4.2.2 AstraZeneca Product Information
      • 4.2.3 AstraZeneca Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 AstraZeneca SWOT Analysis
    • 4.3 Eli Lilly
      • 4.3.1 Eli Lilly Profiles
      • 4.3.2 Eli Lilly Product Information
      • 4.3.3 Eli Lilly Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Eli Lilly SWOT Analysis
    • 4.4 Roche
      • 4.4.1 Roche Profiles
      • 4.4.2 Roche Product Information
      • 4.4.3 Roche Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Roche SWOT Analysis
    • 4.5 GlaxoSmithKline
      • 4.5.1 GlaxoSmithKline Profiles
      • 4.5.2 GlaxoSmithKline Product Information
      • 4.5.3 GlaxoSmithKline Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 GlaxoSmithKline SWOT Analysis
    • 4.6 Novartis
      • 4.6.1 Novartis Profiles
      • 4.6.2 Novartis Product Information
      • 4.6.3 Novartis Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Novartis SWOT Analysis
    • 4.7 Pfizer
      • 4.7.1 Pfizer Profiles
      • 4.7.2 Pfizer Product Information
      • 4.7.3 Pfizer Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Pfizer SWOT Analysis
    • 4.8 Sanofi Pasteur
      • 4.8.1 Sanofi Pasteur Profiles
      • 4.8.2 Sanofi Pasteur Product Information
      • 4.8.3 Sanofi Pasteur Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Sanofi Pasteur SWOT Analysis
    • 4.9 Bayer
      • 4.9.1 Bayer Profiles
      • 4.9.2 Bayer Product Information
      • 4.9.3 Bayer Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Bayer SWOT Analysis
    • 4.10 Celgene
      • 4.10.1 Celgene Profiles
      • 4.10.2 Celgene Product Information
      • 4.10.3 Celgene Influenza DrugsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Celgene SWOT Analysis
    • 4.11 Seqirus
    • 4.12 Protein Sciences Corporation
    • 4.13 Serum Institute of India
    • 4.14 Emergent Biosolutions
    • 4.15 BioCryst Pharmaceuticals
    • 4.16 Alvogen

    5 Market Performance for Manufacturers

    • 5.1 Global Influenza Drugs Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Influenza Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Influenza Drugs Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Influenza Drugs Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Influenza Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Influenza Drugs Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Influenza Drugs Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Influenza Drugs Market Assessment by Regions (2014-2020)

    • 7.1 Global Influenza Drugs Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Influenza Drugs Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Influenza Drugs Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Influenza Drugs Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Influenza Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Influenza Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Adults Industry
    • 11.2 Chidren Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Influenza Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Influenza Drugs Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Influenza Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Zanamivir
      • 12.2.3 Oseltamivir Phosphate
      • 12.2.4 Peramivir
      • 12.2.5 Other Influenza Drugs
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Adults
      • 12.3.3 Chidren
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Influenza Drugs Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Influenza Drugs Gross Profit Trend 2021-2026

    13 Conclusion

    Summary:
    Get latest Market Research Reports on Influenza Drugs. Industry analysis & Market Report on Influenza Drugs is a syndicated market report, published as Global Influenza Drugs Market Research Report 2019 by Manufacturers, Regions, Types and Applications. It is complete Research Study and Industry Analysis of Influenza Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,650.00
    		$7,200.00
    		2,909.05
    		5,738.40
    		3,394.50
    		6,696.00
    		558,012.00
    		1,100,736.00
    		304,519.50
    		600,696.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo